

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Con⦠read more
Healthcare
Diagnostics & Research
10 years
USD
Exclusive to Premium users
$5.20
Price-2.26%
-$0.12
$726.251m
Small
-
Premium
Premium
-436.6%
EBITDA Margin-443.0%
Net Profit Margin-332.1%
Free Cash Flow Margin-436.6%
EBITDA Margin-443.0%
Net Profit Margin-332.1%
Free Cash Flow Margin$8.367m
-15.9%
1y CAGR-17.0%
3y CAGR+72.3%
5y CAGR-$69.662m
-7.3%
1y CAGR-19.4%
3y CAGR-13.5%
5y CAGR-$0.56
+19.3%
1y CAGR-3.6%
3y CAGR+1.5%
5y CAGR$143.649m
$198.720m
Assets$55.071m
Liabilities$1.985m
Debt1.0%
-
Debt to EBITDA-$52.273m
-290.3%
1y CAGR-77.5%
3y CAGR-65.6%
5y CAGR